E-LIB Suche - Ergebnisse für: Hsu, Ping-Chih

1

A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L..:

Hsu, Ping-Chih ; Wu, Bing-Chen ; Wang, Chin-Chou...
Vaccines. 12 (2024) 5 - p. 474 , 2024

Link: https://doi.org/10.3390/..

2

Urinary cadmium concentration is associated with the severi..:

Chiu, Li-Chung ; Lee, Chung-Shu ; Hsu, Ping-Chih...
Environmental Health. 23 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Differential prognostic value of tumor and plasma T790M mut..:

Tung, Pi-Hung ; Chiu, Tzu-Hsuan ; Huang, Allen Chung-Cheng...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

4

Effectiveness and safety of afatinib, gefitinib, and erloti..:

Hung, Ling-Jen ; Hsu, Ping-Chih ; Yang, Cheng-Ta...
Aging. , 2024

Link: https://doi.org/10.18632..

5

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Met..:

Hsu, Ping-Chih ; Chen, Tai-Di ; Tsai, Tsung-Yu.
Clinics and Practice. 13 (2023) 1 - p. 200-205 , 2023

Link: https://doi.org/10.3390/..

6

Brain metastasis, EGFR mutation subtype and generation of E..:

Ju, Jia-Shiuan ; Huang, Allen Chung-Cheng ; Tung, Pi-Hung...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma wit..:

Hsu, Ping-Chih ; Lee, Suey-Haur ; Chiu, Li-Chung...
Targeted Oncology. 18 (2023) 2 - p. 195-207 , 2023

Link: https://doi.org/10.1007/..

8

Afatinib Treatment Alone or with Bevacizumab in a Real-Worl..:

Kuo, Chih-Hsi Scott ; Chiu, Tzu-Hsuan ; Tung, Pi-Hung...
Cancers. 14 (2022) 2 - p. 316 , 2022

Link: https://doi.org/10.3390/..

9

Sequential treatment in advanced non–small cell lung cancer..:

Hsu, Ping-Chih ; Chang, John Wen-Cheng ; Chang, Ching-Fu...
Therapeutic Advances in Respiratory Disease. 16 (2022) - p. 175346662211327 , 2022

Link: https://doi.org/10.1177/..

10

Circulating EGFR Mutations in Patients with Lung Adenocarci..:

Li, Shih-Hong ; Wu, Min-Hsien ; Wang, Hung-Ming...
International Journal of Molecular Sciences. 23 (2022) 18 - p. 10661 , 2022

Link: https://doi.org/10.3390/..

11

Forced Overexpression of Signal Transducer and Activator of..:

Hsu, Ping-Chih ; Li, Jhy-Ming ; Yang, Cheng-Ta
Biomedicines. 10 (2022) 7 - p. 1704 , 2022

Link: https://doi.org/10.3390/..

12

The different overall survival between single-agent EGFR-TK..:

Chiu, Tzu-Hsuan ; Tung, Pi-Hung ; Huang, Chi-Hsien...
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

13

Comparison of Different Tyrosine Kinase Inhibitors for Trea..:

Wu, Chiao-En ; Chang, Ching-Fu ; Huang, Chen-Yang...
Cancers. 14 (2022) 3 - p. 674 , 2022

Link: https://doi.org/10.3390/..

14

Comparison of afatinib and erlotinib combined with bevacizu..:

Lee, Suey-Haur ; Lin, Yu-Ching ; Chiu, Li-Chung...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211132 , 2022

Link: https://doi.org/10.1177/..

15

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mu..:

Chang, John Wen-Cheng ; Huang, Chen-Yang ; Fang, Yueh-Fu...
Cancers. 14 (2022) 4 - p. 977 , 2022

Link: https://doi.org/10.3390/..